Inactive Instrument

Highlights Cassiopea S.p.A.

Equities

SKIN

IT0005108359

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Cassiopea S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 19	CI
Hyphens Pharma Pte. Ltd., Enters into Exclusive License and Supply Agreements with Cassiopea S.p.A. for Exclusive Rights to Develop and Commercialize Winlevi in 10 Countries Across Southeast Asia	22-12-20	CI
Cassiopea To Delist From Swiss Bourse In March After Takeover By Cosmo Pharmaceuticals	22-02-04	MT
Cassiopea to Delist Shares from Swiss Bourse After Takeover by Cosmo	22-01-20	MT
Cosmo Closes Public Exchange Offer For Cassiopea After Amassing 97% Stake	21-12-17	MT
Cosmo Pharmaceuticals Secures Over 93% Stake in Cassiopea at Tender Closing	21-12-03	MT
Cosmo Pharmaceuticals N.V. completed the acquisition of an additional 49.9% stake in Cassiopea S.p.A. from a group of shareholders in a mergers of equal transaction for approximately CHF 160 million.	21-12-01	CI
Cosmo Pharmaceuticals to Start Additional Acceptance Period in Cassiopea Offer	21-11-18	MT
Cosmo Pharmaceuticals Wins Shareholders Nod For Cassiopea Stake Deal	21-11-16	MT
Cosmo Pharmaceuticals Raises Cassiopea Stake To Over 87%	21-11-16	MT
Cassiopea's Partner Launches Winlevi Acne Treatment In US	21-11-03	MT
Cosmo Pharmaceuticals N : Initiates Public Exchange Offer For Cassiopea	21-10-04	MT
Cosmo Pharmaceuticals Intends to Acquire Cassiopea	21-10-03	CI
Cosmo Pharmaceuticals N.V. made an offer to acquire remaining 53.4% stake in Cassiopea S.p.A. from a group of shareholders in a mergers of equal transaction for approximately CHF 210 million.	21-10-03	CI
Cassiopea SpA Announces Topline Results of Phase II Proof of Concept Trial of Clascoterone Solution for the Treatment of Androgenetic Alopecia in Females	21-09-10	CI
Cassiopea S p A : Concludes License, Supply Deal for Acne Drug Winlevi	21-08-31	MT
Cassiopea S p A : H1 Loss Swells to $7 Million	21-07-29	MT
Cassiopea S.p.A. Provides Earnings Guidance for the Year 2021	21-07-29	CI
Sun Pharma and Cassiopea SpA Announce Signing of License and Supply Agreements for Winlevi® (clascoterone cream 1%) in US and Canada	21-07-26	CI
Cassiopea S p A : Enters License, Supply Deals for Acne Treatment in North America	21-07-26	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Cassiopea S.p.A.

Equities

SKIN

IT0005108359

Highlights

Filters